<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01121094</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-09-7502-OG-SMC</org_study_id>
    <nct_id>NCT01121094</nct_id>
  </id_info>
  <brief_title>Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences</brief_title>
  <official_title>Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prospectively evaluated the T2* values of normal feti.A
      standardized scale of T2* values for fetal and neonatal iron organ overload have yet to be
      reported or devised.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to prospectively evaluate the T2* values of normal feti. This
      study will be offered to mothers undergoing fetal MRI for any indication. Subjects will be
      required to sign an informed consent from. The addition of T2* sequences will add 2-4 minutes
      to the whole scan, not exposing the mother or the fetus to ionizing radiation or the
      administration of contrast material. A standardized scale has been created and multi-center
      studies have been conducted using different vendor scanners in order to verify the
      consistency of these scale. T2 and T2* sequences have been addressed anecdotally in the
      literature as non invasive options for the evaluation fetal iron deposition . However, a
      standardized scale of T2* values for fetal and neonatal iron organ overload have yet to be
      reported or devised.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Iron Overload</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be offered to motheres undergoing fetal MRI for any indication.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any MRI study for fetus

        Exclusion Criteria:

          -  Known iron deposition problem in the mother of fetus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Orly Goitein, MD</last_name>
    <phone>+972 3 5302530</phone>
    <email>orly.goitein@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba medical center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Orly Goitein, MD</last_name>
      <phone>+972 3 5302530</phone>
    </contact>
    <investigator>
      <last_name>Orly Goitein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2010</study_first_submitted>
  <study_first_submitted_qc>May 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2010</study_first_posted>
  <last_update_submitted>May 11, 2010</last_update_submitted>
  <last_update_submitted_qc>May 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sheba Medical Center</name_title>
    <organization>Sheba Medical Center</organization>
  </responsible_party>
  <keyword>Liver, spleen , T2* , MRI, fetus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron Overload</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

